1 EXHIBIT 10.3 CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. OPERATING AGREEMENTOperating Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc • Delaware
Contract Type FiledMarch 2nd, 2001 Company Jurisdiction
CONFIDENTIAL CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. JOINT VENTURE AGREEMENTJoint Venture Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc • Texas
Contract Type FiledMarch 2nd, 2001 Company Jurisdiction
EXCLUSIVE LICENSE AGREEMENT GOPAL M. NAIR AND BIONUMERIK PHARMACEUTICALS, INC. FOR MDAM, MEDAM, AND ANALOGSExclusive License Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc • Texas
Contract Type FiledMarch 2nd, 2001 Company Jurisdiction
1 EXHIBIT 10.6 CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. COLLABORATION AGREEMENTCollaboration Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc • Texas
Contract Type FiledMarch 2nd, 2001 Company Jurisdiction
RECITALSJoint Collaboration, Licensing, and Clinical Trials Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc • Maryland
Contract Type FiledMarch 2nd, 2001 Company Jurisdiction
CONFIDENTIAL CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • March 2nd, 2001 • Bionumerik Pharmaceuticals Inc
Contract Type FiledMarch 2nd, 2001 Company